Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Assessment of Anti-Angiogenic Treatment Efficacy in Advanced Renal Cancer by Using Contrast-Enhanced Sonography

NCT01105364 is registered in ClinicalTrials.gov with National Cancer Institute, France as lead sponsor.

NCT NCT01105364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01105364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Assessment of Anti-Angiogenic Treatment Efficacy in Advanced Renal Cancer by Using Contrast-Enhanced Sonography
Lead sponsor
National Cancer Institute, France
Phase
Not applicable
Overall status
Unknown status
Start date
December 31, 2007
Completion date
Not reported
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer, metastatic cancer